欧洲应对套细胞淋巴瘤
Tackling Mantle Cell Lymphoma in Europe.
作者信息
Horgan Denis, Walewski Jan, Aurer Igor, Visco Carlo, Giné Eva, Fetica Bogdan, Jerkeman Mats, Kozaric Marta, da Silva Maria Gomes, Dreyling Martin
机构信息
European Alliance for Personalised Medicine, 1040 Brussels, Belgium.
The Maria Sklodowska-Curie National Research Institute of Oncology, 00-001 Warszawa, Poland.
出版信息
Healthcare (Basel). 2022 Sep 3;10(9):1682. doi: 10.3390/healthcare10091682.
An expert panel convened by the European Alliance for Personalized Medicine (EAPM) reflected on achievements and outstanding challenges in Europe in mantle cell lymphoma (MCL). Through the prism of member state experience, the panel noted advances in outcomes over the last decade, but highlighted issues constituting barriers to better care. The list notably included availability of newer treatments, infrastructure and funding for related testing, and shortages of relevant skills and of research support. The prospect of improvements was held to reside in closer coordination and cooperation within and between individual countries, and in changes in policy and scale of investment at both national and EU levels.
由欧洲个性化医疗联盟（EAPM）召集的一个专家小组，对欧洲套细胞淋巴瘤（MCL）的成就和突出挑战进行了反思。通过成员国经验的视角，该小组指出了过去十年在治疗结果方面的进展，但也强调了构成更好治疗障碍的问题。这份清单特别包括新疗法的可及性、相关检测的基础设施和资金，以及相关技能和研究支持的短缺。改善的前景在于各国国内及相互之间更紧密的协调与合作，以及国家和欧盟层面政策的改变和投资规模的调整。
Zotero 插件